Debasis Gantayat’s Post

New podcast shining a spotlight on cancer research developments This is the latest episode of the free DDW narrated podcast, titled “How to utilise clinical trials in drug discovery” which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: The ‘dark matter’ behind cancer and Could this ‘Goldilocks’ drug be a non-toxic way to treat breast cancer? In the first article, DDW Editor Reece Armstrong looks into recent research which may explain why cancers can become more aggressive. In the second article, Armstrong covers news of a drug which could be used to treat triple-negative breast cancer with less side effects. https://lnkd.in/geQfy3Fn #CancerResearch #Cancer #Oncology

Breaking New Ground in Cancer Treatment with Dr. Nathan Goodyear As we navigate the complexities of cancer, it's essential to explore and integrate cutting-edge therapies that target tumors more precisely and effectively. For an in-depth look at six promising new cancer therapies offering hope in 2024, check out this enlightening article from The Epoch Times: [Six New Cancer Therapies Offering Hope in 2024](https://lnkd.in/gCP-4JKW). Join me in embracing these advancements and working towards a future where innovative, patient-centered care transforms the landscape of cancer treatment! #CancerTreatment #Innovation #IntegrativeMedicine #PatientCare #Oncology #HealthcareRevolution #DrNathanGoodyear

It’s Day 3 of #ESMO2024, and HCPs are driving dynamic discussions on various cancer types. • Lung cancer leads the conversation with over 1,220 posts from HCPs, followed closely by other major cancers: genitourinary and breast cancer. • So far, out of the 11,755 HCP posts discussing ESMO updates, more than half have referenced a specific cancer. • In lung cancer discussions, non-small cell lung cancer research was the most discussed, with 709 posts by 173 HCPs. 👉 Follow CREATION to stay up to date with online #HCP conversations throughout #ESMO #Oncology #CancerResearch #LungCancer #BreastCancer #NSCLC #WhatHCPsThink

We're thrilled to share a major milestone from Antennova! On March 20, 2024, we completed the first dosing cohort in our Phase I PERFORM trial of ATN-031, our pioneering anti-CD24 antibody, aimed at treating advanced solid tumors and B-cell non-Hodgkin’s lymphoma. This clinical trial, conducted at four prestigious cancer centers in the U.S., including the leading University of Texas MD Anderson Cancer Center, has enrolled five late-stage cancer patients using the Bayesian Optimal Interval (BOIN) design. Remarkably, no dose-limiting toxicities have been observed, and we’ve even seen tumor shrinkage in a patient who had previously undergone seven lines of therapy. Stay tuned for more updates as we continue to advance this promising treatment in our fight against cancer. Read more: https://lnkd.in/g4fnehRK #Antennova #Oncology #ClinicalTrials #CancerResearch #Innovation #Healthcare

Cancer has affected my family as well as so many others in devastating ways. The prevalence of this disease is alarmingly increasing. The American Cancer Society found that 1 in 2 males and 1 in 3 females will develop some type of cancer in their lifetime! Over the last decade cancer rates are rising rapidly in the younger population as well. To deter these from growing exponentially, we need more research to find the cure , as well as better treatment options. Today, on #worldcancerday, please consider donating to Cancer Research Institute (CRI) , American Cancer Society or American Institute for Cancer Research, as they are the leading organizations supporting cancer research.❤️🩹 #closethecaregap #awarenessispower

Breast cancer remains the most prevalent cancer globally, accounting for about 12-13% of all new cancer cases. At COD, we are focused on advancing research in Oncology to tackle some of the most challenging cancers, including Breast, Colon, Ovarian, Leukemia, Prostate cancer, and Advanced Non-squamous Non-small-cell Lung cancer (NSCLC), among others. Our comprehensive approach to clinical research enables us to design and execute clinical studies across nearly all significant areas of cancer treatment. Join us today in raising awareness about Breast cancer treatment, management, and the importance of early detection. To know more write to us at bd@cod-research.com Designing Therapies for Future #BreastCancerAwareness #EarlyDetection #BreastCancerResearch #CancerResearch #CODResearch

It's Cancer Immunotherapy Awareness Month! Immunotherapy is a cancer treatment that uses the immune system to attack and kill cancer. Cancer is good at hiding from the immune system, which allows cancerous cells to spread. But immunotherapy helps the immune system recognize and target cancer cells, hindering their spread. Talk with your PCI provider about your options. To learn more: https://loom.ly/mMqqXLA #Cancer #Immunotherapy

For your Monday reading: to build trust 'and refine our scientific questions' - Kimryn Rathmell Dr. Rob Winn National Cancer Institute (NCI) VCU Massey Comprehensive Cancer Center #Cancer #NationalCancerInstitute #NCI #OncoDaily #Oncology

Breast cancer is a cancer that forms in the cells of the breast. A large population of women do not take time to self-examine themselves monthly, thereby reducing the chances of detecting lumps, which can lead to tumours The question is… What if there is something that can help reduce breast cancer deaths globally? For the next 12 weeks, Team Aware will be working on a project that will help the WHO Global Breast Cancer Initiative (GBCI) achieve its objective of reducing global breast cancer mortality by 2.5 per cent per year by coming up with a digital solution to help create awareness about Breast Cancer. #challengebootcamp #teamwork #productsio #BreastCancerAwareness

This will be a really interesting panel discussion considering the importance of Screening for cancer and early identification and treatment. Register following the link and if you register you will be sent the recording later if you cannot attend. #irwinmitchell #cancerscreeing #oncology